N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence

The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with substantial morbidity and mortality. N-acetylcysteine, being a nutraceutical precursor of an important antioxidant glutathione, can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Kon Ken, Lee, Shaun Wen Huey, Kua, Kok Pim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274825/
https://www.ncbi.nlm.nih.gov/pubmed/34262324
http://dx.doi.org/10.2147/JIR.S306849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274825/
https://www.ncbi.nlm.nih.gov/pubmed/34262324
http://dx.doi.org/10.2147/JIR.S306849

Ejemplares similares